Related Experiment Video

Updated: Feb 18, 2026

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
12:21

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues

Published on: November 30, 2013

15.4K

MiR-199a targeting ROCK1 to affect kidney cell proliferation, invasion and apoptosis

Zhigang Qin1, Xin Wei2, Ning Jin2

  • 1a Department of Neurosurgery , China-Japan Union Hospital of Jilin University , Changchun , China.

Artificial Cells, Nanomedicine, and Biotechnology
|November 14, 2017
PubMed

Insights

MicroRNA-199a (miR-199a) acts as a tumor suppressor in kidney cancer. Its low levels in renal cell carcinoma (RCC) correlate with progression, and restoring miR-199a inhibits cancer cell growth and metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Renal cell carcinoma (RCC) accounts for 2-3% of systemic cancers.
  • Recent studies suggest microRNA-199a (miR-199a) may function as a tumor suppressor in RCC.
  • Low expression of miR-199a has been observed in RCC tissues.

Purpose of the Study:

  • To investigate the role of miR-199a in the progression and metastasis of renal cell carcinoma.
  • To determine the molecular mechanisms underlying miR-199a's function in RCC.
  • To evaluate miR-199a as a potential diagnostic and therapeutic target for RCC.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) to assess miR-199a and ROCK1 mRNA levels.
  • Western blot analysis to evaluate ROCK1 protein expression.
  • Cell culture experiments involving miR-199a overexpression in RCC cell lines to assess proliferation, migration, and invasion.

Main Results:

  • miR-199a was significantly downregulated in RCC tissues and cell lines.
  • Overexpression of miR-199a inhibited RCC cell proliferation, migration, and invasion.
  • miR-199a directly targeted ROCK1, downregulating its mRNA and protein levels.
  • ROCK1 was identified as a direct target of miR-199a through binding to its 3' untranslated region.

Conclusions:

  • miR-199a functions as a tumor suppressor in renal cell carcinoma.
  • Downregulation of miR-199a contributes to RCC progression and metastasis, potentially via ROCK1.
  • miR-199a represents a promising novel diagnostic and therapeutic target for RCC treatment.
Keywords:
ROCK-1Renal cell carcinomamechanismmiR-199target genes

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K